相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。5-Alpha Reductase Inhibitors and Prostate Cancer Mortality among Men with Regular Access to Screening and Health Care
Jane B. Vaselkiv et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2022)
Factors Associated with Discontinuation of Active Surveillance among Men with Low-Risk Prostate Cancer: A Population-Based Study
N. Timilshina et al.
JOURNAL OF UROLOGY (2021)
Variation in the Use of Active Surveillance for Low-Risk Prostate Cancer Across US Census Regions
Bashir Al Hussein Al Awamlh et al.
FRONTIERS IN ONCOLOGY (2021)
5α-Reductase Inhibitors and Risk of Prostate Cancer Death
Tiago Bonde Miranda et al.
JOURNAL OF UROLOGY (2020)
Use of Active Surveillance or Watchful Waiting for Low-Risk Prostate Cancer and Management Trends Across Risk Groups in the United States, 2010-2015
Brandon A. Mahal et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Long-Term Effects of Finasteride on Prostate Cancer Mortality
Phyllis J. Goodman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Association of Treatment With 5-Reductase Inhibitors With Time to Diagnosis and Mortality in Prostate Cancer
Reith R. Sarkar et al.
JAMA INTERNAL MEDICINE (2019)
Use of Conservative Management for Low-Risk Prostate Cancer in the Veterans Affairs Integrated Health Care System From 2005-2015
Stacy Loeb et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Risk of Prostate Cancer in Men Treated With 5α-Reductase Inhibitors-A Large Population-Based Prospective Study
Anna Wallerstedt et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Risk of Prostate Cancer in Men Treated With 5α-Reductase Inhibitors-A Large Population-Based Prospective Study
Anna Wallerstedt et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Uptake of Active Surveillance for Very-Low-Risk Prostate Cancer in Sweden
Stacy Loeb et al.
JAMA ONCOLOGY (2017)
5α-Reductase Inhibitors and the Risk of Cancer-Related Mortality in Men With Prostate Cancer
Laurent Azoulay et al.
JAMA ONCOLOGY (2015)
Long-Term Survival of Participants in the Prostate Cancer Prevention Trial
Ian M. Thompson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Use of 5α-reductase inhibitors for lower urinary tract symptoms and risk of prostate cancer in Swedish men: nationwide, population based case-control study
David Robinson et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
The Risks and Benefits of 5α-Reductase Inhibitors for Prostate-Cancer Prevention
Marc R. Theoret et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Knowledge and Use of Finasteride for the Prevention of Prostate Cancer
Robert J. Hamilton et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Effect of Dutasteride on the Risk of Prostate Cancer.
Gerald L. Andriole et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Finasteride improves the sensitivity of digital rectal examination for prostate cancer detection
Ian M. Thompson et al.
JOURNAL OF UROLOGY (2007)
Effect of finasteride on the sensitivity of PSA for detecting prostate cancer
Ian M. Thompson et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Evidence for a biopsy derived grade artifact among larger prostate glands
GS Kulkarni et al.
JOURNAL OF UROLOGY (2006)
The influence of finasteride on the development of prostate cancer
IM Thompson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
分享论文
